Derleme
Yıl 2017,
Cilt: 9 Sayı: 6, 28 - 40, 17.11.2017
Öz
Abstract
Allergic rhinitis is an allergic disease, mediated by type I allergic mechanisms. It is an inflammation of the nasal membranes. Characteristic clinical findings are sneezing, nasal congestion, nasal itching and rhinorrhea, in any combination. Laboratory tests used in the diagnosis of allergic rhinitis include allergy skin tests, specific IgE measurements, and imaging studies. The management of allergic rhinitis consists of the environmental control, pharmacologic management and immunotherapy. This paper reviews the diagnosis and treatment strategies of allergic rhinitis in the light of recent studies and guidelines.
Anahtar Kelimeler
Allergic rhinitis diagnosis environmental control therapy quality of life
Kaynakça
- Kaynaklar 1.Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhini-tis and its impact on asthma. J Allergy Clin Immunol 2001;108 (Suppl. 5): S147–S334. 2.International Consensus Report on Diagnosis and Manage-ment of Rhinitis. International Rhinitis Management WorkingGroup. Allergy 1994; 49 (Suppl. 19): 1–34. 3.Fokkens WJ. Thoughts on the pathophysiology of nonallergicrhinitis. Curr Allergy Asthma Rep 2002; 2: 203–209. 4.Fokkens W, Lund V, Bachert C, et al. EAACI position paperon rhinosinusitis and nasal polyp’s executive summary. Allergy2005; 60: 583–601. 5.Dykewicz MS, Fineman S. Executive summary of Joint TaskForce Practice Parameters on Diagnosis and Management ofRhinitis. Ann Allergy Asthma Immunol 1998; 81: 463–68. 6.Van-Cauwenberge P, Bachert C, Passalacqua G, et al. Con-sensus statement on the treatment of allergic rhinitis. EAACIPosition paper. Allergy 2000; 55: 116–34. 7.Bousquet J, Khaltaev N, Cruzz AA, et al. Allergic Rhinitis andIts Impact on Asthma (ARIA) 2008 update (in collaborationwith the World Health Organization, GA(2)LEN and AllerGen).Allergy 2008; (63): 8-160.8.Tuncer A, Yüksel H. Ulusal Alerji Tanı ve tedavi Rehberi. Ulu-sal Allerji ve İmmunoloji Derneği, 2012. 9.Dykewicz MS, Fineman S. Executive summary of Joint TaskForce Practice Parameters on Diagnosis and Management ofRhinitis. Ann Allergy Asthma Immunol 1998; 81: 463–68. 10.Dykewicz MS. Rhinitis and sinusitis. J Allergy Clin Immunol2003; 111 (Suppl. 2): S520–S529. 11.van Cauwenberge P, Bachert C, Passalacqua G, et al. Con-sensus statement on the treatment of allergic rhinitis. Euro-pean Academy of Allergology and Clinical Immunology. Al-lergy 2000; 55: 116–34. 12.Riediker M, Monn C, Koller T, Stahel WA, Wuthrich B. Air pol-lutants enhance rhinoconjunctivitis symptoms in pollen aller-gic individuals. Ann Allergy Asthma Immunol 2001; 87: 311–18. 13.Nascimento Silva M, Naspitz C, Sole D. Evaluation of qua-lity of life in children and teenagers with allergic rhinitis: adap-tation and validation of the Rhinoconjunctivitis Quality of LifeQuestionnaire (RQLQ). Allergol Immunopathol (Madr) 2001;29: 111–18. 14.Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Validati-on of the standardized version of the Rhinoconjunctivitis Qua-lity of Life Questionnaire. J Allergy Clin Immunol 1999; 104:364–69. 15.Spector SL, Nicklas RA, Chapman JA, et al. Symptom seve-rity assessment of allergic rhinitis: part 1. Ann Allergy Asth-ma Immunol 2003; 91: 105–14. 16.Clement PA, Gordts F. Consensus report on acoustic rhino-metry and rhinomanometry. Rhinology 2005; 43: 169–79. 17.Ragab SM, Lund VJ, Saleh HA, Scadding G. Nasal nitric oxi-de in objective evaluation of chronic rhinosinusitis therapy.Allergy 2006; 61: 717–24. 18.Litvyakova LI, Baraniuk JN. Nasal provocation testing: a re-view. Ann Allergy Asthma Immunol 2001; 86: 355–64. 19.Moll B, Klimek L, Eggers G, Mann W. Comparison of olfac-tory function in patients with seasonal and perennial allergicrhinitis. Allergy 1998; 53: 297–301. 20.Bousquet PJ, Combescure C, Neukirch F, et al. Visual analog scales can assess the severity of rhinitis graded according toARIA guidelines. Allergy 2007; 62: 367–72. 21.Yorgancıoğlu A, Özdemir C, Kalaycı Ö, et al; WHO Collabo-rating Center on Asthma and Rhinitis. [ARIA (Allergic Rhi-nitis and its Impact on Asthma) achievements in 10 years andfuture needs]. Tuberk Toraks 2012; 60: 92-97. 22.Barnes K, Marsh D. The genetics and complexity of allergyand asthma. Immunol Today 1998; 19: 325–32. 23.Kurz T, Altmueller J, Strauch K, et al. A genome-wide scre-en on the genetics of atopy in a multiethnic European popu-lation reveals a major atopy locus on chromosome 3q21.3. Al-lergy 2005; 60: 192–99. 24.Strachan DP. Is allergic disease programmed in early life? [edi-torial; comment]. Clin Exp Allergy 1994; 24 :603–605. 25.von Mutius E, Weiland SK, Fritzsch C, Duhme H, Keil U. In-creasing prevalence of hay fever and atopy among childrenin Leipzig, East Germany. Lancet 1998; 351: 862–66. 26.Stazi MA, Sampogna F, Montagano G, Grandolfo ME, CouilliotMF, Annesi Maesano I. Early life factors related to clinical ma-nifestations of atopic disease but not to skin prick test positivityin young children. Pediatr Allergy Immunol 2002; 13: 105–12. 27.Bjorksten F, Suoniemi I, Koski V. Neonatal birch pollen con-tact and subsequent allergy to birch pollen. Clin Allergy 1980;10: 585–91. 28.Tedeschi A, Barcella M, Bo GA, Miadonna A. Onset of allergyand asthma symptoms in extra European immigrants to Mi-lan, Italy: possible role of environmental factors. Clin Exp Al-lergy 2003; 33: 449–54. 29.Stewart GA, Thompson PJ. The biochemistry of common ae-roallergens. Clin Exp Allergy 1996; 26: 1020–44. 30.Boulet LP, Turcotte H, Laprise C, et al. Comparative degreeand type of sensitization to common indoor and outdoor al-lergens in subjects with allergic rhinitis and/or asthma. ClinExp Allergy 1997; 27: 52–59. 31.Braun-Fahrlander C, Wuthrich B, Gassner M, et al. Valida-tion of a rhinitis symptom questionnaire (ISAAC core questi-ons) in a population of Swiss school children visiting the scho-ol health services. SCARPOL team. Swiss Study on Childho-od Allergy and Respiratory Symptom with respect to Air Pol-lution and Climate. International Study of Asthma and Aller-gies in Childhood. Pediatr Allergy Immunol 1997; 8: 75–82. 32.Gergen PJ, Turkeltaub PC. The association of individual al-lergen reactivity with respiratory disease in a national sam-ple: data from the second National Health and Nutrition Exa-mination Survey, 1976-80 (NHANES II). J Allergy Clin Immu-nol 1992; 90: 579–88. 33.Wan H, Winton HL, Soeller C, et al. Der p 1 facilitates tran-sepithelial allergen delivery by disruption of tight junctions.J Clin Invest 1999; 104: 123–33. 34.Pichavant M, Charbonnier AS, Taront S, et al. Asthmatic bronc-hial epithelium activated by the proteolytic allergen Der p 1increases selective dendritic cell recruitment. J Allergy ClinImmunol 2005; 115: 771–78. 35.Lintner TJ, Brame KA. The e
Yıl 2017,
Cilt: 9 Sayı: 6, 28 - 40, 17.11.2017
Öz
Öz
Allerjik rinit, tip I alerji mekanizmalarının neden olduğu bir alerjik hastalıktır. Nazal membranların inflamasyonudur. En önemli klinik bulguları hapşırık, burun tıkanıklığı ve burun akıntısıdır, birkaçı bir arada görülebilir. Tanısı için en çok başvurulan testler alerji deri testleri, spesifik IgE ölçümleri ve görüntüleme çalışmalarıdır. Alerjik rinitin tedavisinde çevre kontrolü, farmakolojik tedavi ve immünoterapidir. Bu yazıda alerjik rinitin tanı ve tedavi stratejileri yeni araştırmalar ve rehberler ışığında ele alınmaktadır.
Anahtar Kelimeler
Kaynakça
- Kaynaklar 1.Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhini-tis and its impact on asthma. J Allergy Clin Immunol 2001;108 (Suppl. 5): S147–S334. 2.International Consensus Report on Diagnosis and Manage-ment of Rhinitis. International Rhinitis Management WorkingGroup. Allergy 1994; 49 (Suppl. 19): 1–34. 3.Fokkens WJ. Thoughts on the pathophysiology of nonallergicrhinitis. Curr Allergy Asthma Rep 2002; 2: 203–209. 4.Fokkens W, Lund V, Bachert C, et al. EAACI position paperon rhinosinusitis and nasal polyp’s executive summary. Allergy2005; 60: 583–601. 5.Dykewicz MS, Fineman S. Executive summary of Joint TaskForce Practice Parameters on Diagnosis and Management ofRhinitis. Ann Allergy Asthma Immunol 1998; 81: 463–68. 6.Van-Cauwenberge P, Bachert C, Passalacqua G, et al. Con-sensus statement on the treatment of allergic rhinitis. EAACIPosition paper. Allergy 2000; 55: 116–34. 7.Bousquet J, Khaltaev N, Cruzz AA, et al. Allergic Rhinitis andIts Impact on Asthma (ARIA) 2008 update (in collaborationwith the World Health Organization, GA(2)LEN and AllerGen).Allergy 2008; (63): 8-160.8.Tuncer A, Yüksel H. Ulusal Alerji Tanı ve tedavi Rehberi. Ulu-sal Allerji ve İmmunoloji Derneği, 2012. 9.Dykewicz MS, Fineman S. Executive summary of Joint TaskForce Practice Parameters on Diagnosis and Management ofRhinitis. Ann Allergy Asthma Immunol 1998; 81: 463–68. 10.Dykewicz MS. Rhinitis and sinusitis. J Allergy Clin Immunol2003; 111 (Suppl. 2): S520–S529. 11.van Cauwenberge P, Bachert C, Passalacqua G, et al. Con-sensus statement on the treatment of allergic rhinitis. Euro-pean Academy of Allergology and Clinical Immunology. Al-lergy 2000; 55: 116–34. 12.Riediker M, Monn C, Koller T, Stahel WA, Wuthrich B. Air pol-lutants enhance rhinoconjunctivitis symptoms in pollen aller-gic individuals. Ann Allergy Asthma Immunol 2001; 87: 311–18. 13.Nascimento Silva M, Naspitz C, Sole D. Evaluation of qua-lity of life in children and teenagers with allergic rhinitis: adap-tation and validation of the Rhinoconjunctivitis Quality of LifeQuestionnaire (RQLQ). Allergol Immunopathol (Madr) 2001;29: 111–18. 14.Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Validati-on of the standardized version of the Rhinoconjunctivitis Qua-lity of Life Questionnaire. J Allergy Clin Immunol 1999; 104:364–69. 15.Spector SL, Nicklas RA, Chapman JA, et al. Symptom seve-rity assessment of allergic rhinitis: part 1. Ann Allergy Asth-ma Immunol 2003; 91: 105–14. 16.Clement PA, Gordts F. Consensus report on acoustic rhino-metry and rhinomanometry. Rhinology 2005; 43: 169–79. 17.Ragab SM, Lund VJ, Saleh HA, Scadding G. Nasal nitric oxi-de in objective evaluation of chronic rhinosinusitis therapy.Allergy 2006; 61: 717–24. 18.Litvyakova LI, Baraniuk JN. Nasal provocation testing: a re-view. Ann Allergy Asthma Immunol 2001; 86: 355–64. 19.Moll B, Klimek L, Eggers G, Mann W. Comparison of olfac-tory function in patients with seasonal and perennial allergicrhinitis. Allergy 1998; 53: 297–301. 20.Bousquet PJ, Combescure C, Neukirch F, et al. Visual analog scales can assess the severity of rhinitis graded according toARIA guidelines. Allergy 2007; 62: 367–72. 21.Yorgancıoğlu A, Özdemir C, Kalaycı Ö, et al; WHO Collabo-rating Center on Asthma and Rhinitis. [ARIA (Allergic Rhi-nitis and its Impact on Asthma) achievements in 10 years andfuture needs]. Tuberk Toraks 2012; 60: 92-97. 22.Barnes K, Marsh D. The genetics and complexity of allergyand asthma. Immunol Today 1998; 19: 325–32. 23.Kurz T, Altmueller J, Strauch K, et al. A genome-wide scre-en on the genetics of atopy in a multiethnic European popu-lation reveals a major atopy locus on chromosome 3q21.3. Al-lergy 2005; 60: 192–99. 24.Strachan DP. Is allergic disease programmed in early life? [edi-torial; comment]. Clin Exp Allergy 1994; 24 :603–605. 25.von Mutius E, Weiland SK, Fritzsch C, Duhme H, Keil U. In-creasing prevalence of hay fever and atopy among childrenin Leipzig, East Germany. Lancet 1998; 351: 862–66. 26.Stazi MA, Sampogna F, Montagano G, Grandolfo ME, CouilliotMF, Annesi Maesano I. Early life factors related to clinical ma-nifestations of atopic disease but not to skin prick test positivityin young children. Pediatr Allergy Immunol 2002; 13: 105–12. 27.Bjorksten F, Suoniemi I, Koski V. Neonatal birch pollen con-tact and subsequent allergy to birch pollen. Clin Allergy 1980;10: 585–91. 28.Tedeschi A, Barcella M, Bo GA, Miadonna A. Onset of allergyand asthma symptoms in extra European immigrants to Mi-lan, Italy: possible role of environmental factors. Clin Exp Al-lergy 2003; 33: 449–54. 29.Stewart GA, Thompson PJ. The biochemistry of common ae-roallergens. Clin Exp Allergy 1996; 26: 1020–44. 30.Boulet LP, Turcotte H, Laprise C, et al. Comparative degreeand type of sensitization to common indoor and outdoor al-lergens in subjects with allergic rhinitis and/or asthma. ClinExp Allergy 1997; 27: 52–59. 31.Braun-Fahrlander C, Wuthrich B, Gassner M, et al. Valida-tion of a rhinitis symptom questionnaire (ISAAC core questi-ons) in a population of Swiss school children visiting the scho-ol health services. SCARPOL team. Swiss Study on Childho-od Allergy and Respiratory Symptom with respect to Air Pol-lution and Climate. International Study of Asthma and Aller-gies in Childhood. Pediatr Allergy Immunol 1997; 8: 75–82. 32.Gergen PJ, Turkeltaub PC. The association of individual al-lergen reactivity with respiratory disease in a national sam-ple: data from the second National Health and Nutrition Exa-mination Survey, 1976-80 (NHANES II). J Allergy Clin Immu-nol 1992; 90: 579–88. 33.Wan H, Winton HL, Soeller C, et al. Der p 1 facilitates tran-sepithelial allergen delivery by disruption of tight junctions.J Clin Invest 1999; 104: 123–33. 34.Pichavant M, Charbonnier AS, Taront S, et al. Asthmatic bronc-hial epithelium activated by the proteolytic allergen Der p 1increases selective dendritic cell recruitment. J Allergy ClinImmunol 2005; 115: 771–78. 35.Lintner TJ, Brame KA. The e
Toplam 1 adet kaynakça vardır.
Ayrıntılar
| Birincil Dil | Türkçe |
|---|---|
| Bölüm | makale |
| Yazarlar | |
| Yayımlanma Tarihi | 17 Kasım 2017 |
| Yayımlandığı Sayı | Yıl 2017 Cilt: 9 Sayı: 6 |
